monoclonal GAST Antibody(Ascites)
- Known as:
- mab GAST Antibody(Ascites)
- Catalog number:
- KA5650
- Product Quantity:
- 0.1 ml
- Category:
- -
- Supplier:
- KareBay
- Gene target:
- monoclonal GAST Antibody(Ascites)
Related genes to: monoclonal GAST Antibody(Ascites)
- Gene:
- GAST NIH gene
- Name:
- gastrin
- Previous symbol:
- GAS
- Synonyms:
- -
- Chromosome:
- 17q21.2
- Locus Type:
- gene with protein product
- Date approved:
- 2001-06-22
- Date modifiied:
- 2015-08-25
Related products to: monoclonal GAST Antibody(Ascites)
Related articles to: monoclonal GAST Antibody(Ascites)
- We report the unique properties of cosmic phosphorus (P), chlorine (Cl), argon (Ar), potassium (K), and calcium (Ca) fluxes in the GV to TV rigidity range collected by the Alpha Magnetic Spectrometer (AMS) on the International Space Station. With a total of one million events collected over 13.5 years, we observed that the rigidity dependencies of the five fluxes are well described by the sums of a primary cosmic ray component and a secondary cosmic ray component. The abundance ratios of all five elements to Si at the source are accurately determined independent of cosmic ray propagation. The source abundance of Ar and Ca (even-Z elements) is larger than P, Cl, and K (odd-Z elements). The secondary components of the P and the Cl fluxes are each ∼1/3 of the F flux, and the secondary components of the Ar, K, and Ca fluxes are each ∼1/2 of the F flux. The twenty elements measured by AMS, from He to Ca and Fe, can be categorized into four classes, two primary and two secondary, based on their rigidity dependence. - Source: PubMed
Aceituno AAguilar MAlpat BAmbrosi GAnderson HAntunes JArruda LAttig NBagwell CBarao FBarbanera MBarrin LBartoloni ABattiston RBayyari ABelyaev NBertucci BBindi VBollweg KBolster JBorchiellini MBorgia BBoschini M JBourquin MBrugnoni CBurger W JCai H YCai X DCapell MCasaus JCassidy JCastellini GCervelli FChang Y HChen G MChen G RChen HChen HChen H SChen YCheng LChou H YChouridou SChoutko VChung C HClark CCoignet GConsolandi CContin ACorti CCui Y XCui ZDadzie KD'Angelo FDass ADelgado CDella Torre SDemirköz M BDerome LDi Falco SDi Felice VDíaz CDimiccoli Fvon Doetinchem PDong FDotson MDuranti MEgorov AEllison AFaldi FFehr DFeng JFiandrini EFisher PFormato VGarcía-López R JGaldames AGargiulo CGast HGe T TGervasi MGhezzer L EGiovacchini FGómez-Coral D MGong JGrandi DGraziani MGuidetti RGuan CHe Z HHeber BHernández-Nicolás FHöfer LHsieh T HHu J YHuang B WIonica MIncagli MJia YiJinchi HKappe TKaradöller EKaragöz GKastelic JKirn ThKounina OKounine AKoutsenko VKrasnopevtsev DKuhlman AKulemzin ALa Vacca GLaudi ELaurenti GLazzizzera ILee H TLee S CLi H LLi J HLi J QLi MLi QLi QLi Q YLi S LLi Z HLiao PLin C HLippert TLiu P CLiu ZLu S QLuo J ZLuo QLuo S DLuo XiMañá CMarín JMartínez GMasi NMaurin DMedvedeva TMenchaca-Rocha AMeng QMikhailov V VMolero MMott PMussolin LNajafi Jozani YNicolaidis RNikonov NNozzoli FOcampo-Peleteiro JOliva AOrcinha MPalmonari FPaniccia MPashnin APauluzzi MPelosi DPensotti SPerez DPietzcker PPlyaskin VPoluianov SPridöhl DPuccetti NQu Z YQuadrani LRafiei M MRancoita P GRapin DRobyn ERodríguez-García IRomaneehsen LRossi FRozhkov ARozza DSagdeev RSchael SSchultz von Dratzig ASchwering GSeo E SShan B SShukla ASiedenburg TSiemko ASilvestre GSchledewitz DSong J WSong X JSonnabend RStrekalovsky AStrigari LStuzhin ASu TSun QSun Z TTabarroni LTacconi MTang Z CTeoh J JTian JTian YeTian YTing Samuel C CTing S MTomassetti NTorsti JUbaldi AUsoskin IVagelli VVainio RVäisänen PValencia-Otero MValente EValtonen EVan Hove EVázquez Acosta MVecchi MVelasco MWang J CWang L QWang N HWang SWang XWang Z MWaqas MWeng Z LWu HWu Z BXiao J NXiong R QXiong Y ZXu WYan QYan Z XYang H TYang YYi HYou Y HYu MYu Y MYu Z QYuan B QZhang CZhang F ZZhang JZhang J HZhang ZZhao P WZheng Z MZhou H FZhuang H LZhukov VZou L KZuberi MZuccon P - Little is known about the presence of resistant micro-organisms in people with intellectual disabilities (ID) residing in long-term care facilities (LTCFs). We explored the resistant percentages of six highly resistant micro-organisms (HRMOs) among people with ID in ID-LTCFs: ESBL-producing (ESBL-E), carbapenemase-producing (CPE), spp. (CPA) and (CPPA), MRSA and VRE. - Source: PubMed
Publication date: 2026/07/04
Hidad SoemejaAltorf-Van Der Kuil WiekeDe Haan FreekLeusink GeralineTimen AuraSchoffelen Annelot FDe Greeff Sabine C - Methylene bis-benzotriazolyl tetramethylbutylphenol (MBBT) is a UV filter and UV absorber used in cosmetics. In this study, the acute toxicity, repeated dose toxicity, skin irritation, ocular irritation, skin sensitization, reproductive, and developmental toxicity, genotoxicity, carcinogenicity, toxicokinetics, and dermal absorption of MBBT were evaluated. The oral and dermal LDs of non-nanoform MBBT in rats were 2 g/kg. The LC of nanoform MBBT in rats was 0.488 mg/L. Neither 20% nanoform MBBT nor 65% non-nanoform MBBT caused skin irritation. Moreover, 50% nanoform MBBT did not cause ocular irritation and 30% non-nanoform MBBT did not induce skin sensitization. In reproductive and developmental toxicity studies in rats, neither male nor pregnant female rats nor fetuses exhibited adverse effects after receiving up to 1000 mg/kg/day of non-nanoform MBBT. In vitro bacterial reverse mutation assays, micronucleus tests, and gene mutation assays, as well as in vivo micronucleus assays, yielded negative results. The NOAEL of MBBT was determined to be 1000 mg/kg/day (the highest dose tested) on the basis of the results of a 90-day repeated dermal toxicity study in rats. The NOAEL was optimized to the internal dose by applying a dermal absorption rate of 5.922%, resulting in a systemic point of departure (PODsys) for MBBT of 59.22 mg/kg/day. The systemic exposure dose was calculated to be 0.0136 mg/kg/day. The margin of safety of MBBT was calculated to be greater than 100 when used at a concentration of 10% as a UV filter in all cosmetic products, suggesting that its use as a cosmetic ingredient is safe under the current usage conditions. - Source: PubMed
Publication date: 2026/05/16
Kim MinhyukKim Su BinLee Jung DaeYoon TaehyungKim Kyu-BongKwack Seung JunLee Joo Young - - Source: PubMed
Publication date: 2026/07/06
Kawamoto AmiTakenaka KentoTsuchiya JunichiWakui MomoOhtsuka KazuoOkamoto Ryuichi - Leaf angle is a key agronomic trait that determines plant architecture and grain yield in rice. Although brassinosteroids (BRs) are known to play a central role in regulating leaf angle, the upstream transcriptional regulatory network remains elusive. Here, we characterized the lla (large leaf angle) mutant which carried a T-DNA insertion in the promoter of OsWRKY11 (a WRKY transcription factor) and exhibits significantly enlarged leaf angles at both seedling and mature stages. We demonstrated that the large leaf angle phenotype of lla was caused by the T-DNA insertion in the promoter of OsWRKY11, leading to its pronounced upregulation. Overexpression of OsWRKY11 recapitulated the lla phenotype, whereas knockdown of OsWRKY11 in the lla background restored leaf angle to wild-type levels, establishing OsWRKY11 as a positive regulator of this trait. Interestingly, the lla mutants are hypersensitive to exogenous BR treatment and accumulate higher levels of the bioactive BR castasterone. Further analyses showed that OsWRKY11 directly binds to W-box elements in the promoter of OsGSR1(a GAST family protein), a known positive regulator of BR biosynthesis, and activates its transcription. Genetic analysis revealed that OsWRKY11 acts upstream of OsGSR1 in the same genetic pathway to regulate leaf angle. Together, our findings uncover an OsWRKY11-OsGSR1 module that fine-tunes leaf angle by modulating BR homeostasis. - Source: PubMed
Publication date: 2026/06/30
Wu LianGao XiuqingWang DekaiSun ShuhuiLi JingCao YuxinChu JinfangLi YuXu RanLi YunhaiLi Na